alfresa -Alfresa Pharma Corporation-

For many people

For one person

As long as there are

Through the entire healthcare process, from diagnosis, to treatment, to prevention

Research and development, production, sales, Contract Manufacturing

From Japan to the world

From the world to Japan

For the health of all the world's people We are taking on the challenge of Unmet Medical Needs

2019/12/27: Notice regarding Receipt of The Investigation Report from Third-Party Special Investigation Committee

2019/11/29: Notice regarding On-site Inspection at a Consolidated Subsidiary (Alfresa Corporation) by the Japan Fair Trade Commission

2019/11/06: Summary of Consolidated Financial Statements for the Second Quarter Ended September 30, 2018

2019/11/06: Financial Results Summary for the Second Quarter Ended September 30, 2019

2019/10/01: Notice regarding Extension of Investigation Period by Third-Party Special Investigation Committee

: Company Information Index; President Message; Profile; Basic Philosophy; Production System; Reliability Assurance System; Financial Statementes

: Business Domain Index; Pharmaceuticals; Diagnostic Reagents; Medical Devices & Equipment; International Business; API Business; Contract Manufacturing